This European Standard specifies requirements and provides guidance for the application of Braille to the labelling of medicinal products. NOTE 1 The labelling of medicinal products placed on the market and incorporating Braille in accordance with this European Standard meets the requirements of European Directive 2001/83/EC, Article 56, (a) as amended by Directive 2004/27/EC [1]. NOTE 2 The principles in this European Standard can be applied in other sectors, as appropriate.